Teliga-Czajkowska et al. presented that a high t-PA plasma level at the onset of chemotherapy was associated with shorter OS and DFS in patients with ovarian cancer, but they found no significant differences in DFS and OS after three and six cycles of chemotherapy [30]. This evidence concerns the gene PLAT and ovarian cancer.